Soquelitinib
Soquelitinib is an experimental drug which acts as a selective inhibitor of the enzyme interleukin-2-inducible T-cell kinase. It is in clinical trials for the treatment of T-cell lymphoma.
Soquelitinib is an experimental drug which acts as a selective inhibitor of the enzyme interleukin-2-inducible T-cell kinase. It is in clinical trials for the treatment of T-cell lymphoma.